ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure
NCT ID: NCT01813331
Last Updated: 2013-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
660 participants
OBSERVATIONAL
2012-11-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network
NCT05753553
Adherence to Medication in Patients With Acute Decompensated Heart Failure
NCT06459115
Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure
NCT00514384
Heart Failure Decompensation And In-Hospital Mortality
NCT04127162
1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)
NCT02353481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Heart Failure Patients
Chronic Heart Failure patients older than 65 years, which accept to participate to the study and give their informed written consent and consecutively refer to the A.R.C.A Campania Cardiologists in the pertaining healthcare districts.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signature of informed consent
* Age older than 65 years
Exclusion Criteria
* age less than 65 years
* inability to perform periodic checks
* presence of malignant neoplasms and other severe diseases.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oliviero Ugo
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ARCA Campania healthcare ambulatories
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
161/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.